| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8711723 | Annals of Allergy, Asthma & Immunology | 2018 | 8 Pages |
Abstract
Compared with morning dosing, ICSs administered once daily in the evening seemed to provide some benefits in lung function for patients with asthma. However, because of methodologic limitations, further large-scale randomized clinical trials for dosing time of once-daily ICSs are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Jae-Uk MD, PhD, Hye Kyeong MD, PhD, Jonghoo MD, PhD,